Re: Using estimated GFR values to identify patients at risk from iodinated contrast-induced nephropathy: a reply

2007 ◽  
Vol 62 (3) ◽  
pp. 285
Author(s):  
W.D. Adair ◽  
J. Entwisle ◽  
K. Harris
2012 ◽  
Vol 32 (6) ◽  
pp. 15-24 ◽  
Author(s):  
Stephen P. Wood

Contrast-induced nephropathy is an iatrogenic disease caused by the administration of iodinated contrast material to certain at-risk patients. The clinical features include renal failure, with oliguria, anuria, and electrolyte derangements. Contrast-induced nephropathy can prolong hospitalization, result in greater morbidity and mortality, and increase patients’ costs. A variety of preventive and treatment strategies exist, including use of alternative imaging. Critical care nurses need to understand the nephropathy and the patients at risk and to develop a familiarity with prevention, treatment, and outcome.


2002 ◽  
Vol 57 (2) ◽  
pp. 132-135 ◽  
Author(s):  
Eli Konen ◽  
Osnat Konen ◽  
Miriam Katz ◽  
Yair Levy ◽  
Judith Rozenman ◽  
...  

2013 ◽  
Vol 33 (1) ◽  
pp. 37-46 ◽  
Author(s):  
Ann L. Jorgensen

Contrast-induced nephropathy is the third most common cause of hospital-acquired renal failure, after decreased renal perfusion and nephrotoxic medications. Identification of patients at risk and implementation of preventive strategies can decrease the incidence of this nephropathy. Prevention strategies focus on counteracting vasoconstriction, enhancing blood flow through the nephron, and providing protection against injury by oxygen free radicals. Knowledge of the adverse effects associated with infusion of contrast media, identification of patients at risk for contrast-induced nephropathy, and application of evidence-based prevention strategies allow nurses to assist in the prevention of contrast-induced nephropathy.


2012 ◽  
Vol 42 (2) ◽  
pp. 118-120
Author(s):  
The-Phung To ◽  
Fahd Chahadi ◽  
Melanie Freeman ◽  
Mary Pan ◽  
Omar Farouque ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document